Does posterior cortical atrophy on MRI discriminate between Alzheimer's disease, dementia with Lewy bodies, and normal aging?

被引:24
|
作者
O'Donovan, James [1 ]
Watson, Rosie [1 ]
Colloby, Sean J. [1 ]
Firbank, Michael J. [1 ]
Burton, Emma J. [1 ]
Barber, Robert [1 ]
Blamire, Andrew. M. [2 ,3 ]
O'Brien, John T. [1 ]
机构
[1] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England
[2] Newcastle Univ, Newcastle Magnet Resonance Ctr, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England
[3] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England
基金
英国惠康基金;
关键词
Alzheimer's disease; dementia with Lewy bodies; MRI; TEMPORAL-LOBE ATROPHY; COGNITIVE IMPAIRMENT; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; DLB; RECOMMENDATIONS; MANAGEMENT; PATHOLOGY;
D O I
10.1017/S1041610212001214
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background: Previous studies suggest that posterior cortical atrophy may be a useful marker for early onset Alzheimer's disease (AD). Dementia with Lewy bodies (DLB) is associated with less temporal lobe atrophy than AD, though posterior cortical atrophy may be greater. Therefore, we assessed whether visual rating scales for assessing posterior atrophy (PA), medial temporal lobe atrophy (MTA), and ventricular enlargement (VEn) aid in the discrimination between AD, DLB, and normal aging. Methods: T1-weighted MRI scans acquired at 3 Tesla were visually rated for PA (range 0-3), MTA (range 0-4), and VEn (range 0-3) in older subjects with AD (n = 36), DLB (n = 35), and healthy controls (n = 35). The diagnostic utility of MTA, PA, and VEn visual ratings in distinguishing AD and DLB from controls as well as AD from DLB was investigated. Results: Significantly higher MTA ratings were associated with AD and DLB compared to controls (p < 0.001). MTA ratings were greater in AD relative to DLB (U = 384.5, p = 0.004). For PA ratings, scores did not differ between groups (p = 0.20). VEn ratings were significantly higher in AD and DLB compared to controls (p = 0.003), but similar between AD and DLB (U = 384.5, p = 0.4). Conclusions: Unlike findings reported in younger subjects, visual ratings for PA are not a reliable marker at older ages for distinguishing AD from controls, or for distinguishing DLB from AD. However, visual ratings of MTA and VEn may be useful markers in distinguishing both AD and DLB from older subjects without dementia.
引用
收藏
页码:111 / 119
页数:9
相关论文
共 50 条
  • [1] Atrophy of the putamen in dementia Lewy bodies but not Alzheimer's disease - An MRI study
    Cousins, DA
    Burton, EJ
    Burn, D
    Gholkar, A
    McKeith, IG
    O'Brien, JT
    NEUROLOGY, 2003, 61 (09) : 1191 - 1195
  • [2] CSF α-Synuclein Does Not Discriminate Dementia with Lewy Bodies from Alzheimer's Disease
    Reesink, Fransje E.
    Lemstra, Afina W.
    van Dijk, Karin D.
    Berendse, Henk W.
    van de Berg, Wilma D. J.
    Klein, Martin
    Blankenstein, Marinus A.
    Scheltens, Philip
    Verbeek, Marcel M.
    van der Flier, Wiesje M.
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 22 (01) : 87 - 95
  • [3] Progressive cortical thinning and subcortical atrophy in dementia with Lewy bodies and Alzheimer's disease
    Mak, Elijah
    Sua, Li
    Williams, Guy B.
    Watson, Rosie
    Firbank, Michael J.
    Blamire, Andrew M.
    O'Brien, John T.
    NEUROBIOLOGY OF AGING, 2015, 36 (04) : 1743 - 1750
  • [4] Posterior cortical atrophy initially presenting as dementia with Lewy bodies
    Yoo, Sang-Won
    Kim, Joong-Seok
    Lee, Kwang-Soo
    NEUROLOGICAL SCIENCES, 2020, 41 (06) : 1607 - 1609
  • [5] Posterior cortical atrophy initially presenting as dementia with Lewy bodies
    Sang-Won Yoo
    Joong-Seok Kim
    Kwang-Soo Lee
    Neurological Sciences, 2020, 41 : 1607 - 1609
  • [6] Visual Impairments in Dementia With Lewy Bodies and Posterior Cortical Atrophy
    Metzler-Baddeley, Claudia
    Baddeley, Roland J.
    Lovell, Paul G.
    Laffan, Amanda
    Jones, Roy W.
    NEUROPSYCHOLOGY, 2010, 24 (01) : 35 - 48
  • [7] Neuropsychological differentiation of dementia with Lewy bodies from normal aging and Alzheimer's disease
    Ferman, Tanis J.
    Smith, Glenn E.
    Boeve, Bradley F.
    Graff-Radford, Neill R.
    Lucas, John A.
    Knopman, David S.
    Petersen, Ronald C.
    Ivnik, Robert J.
    Wszolek, Zbigniew
    Uitti, Ryan
    Dickson, Dennis W.
    CLINICAL NEUROPSYCHOLOGIST, 2006, 20 (04) : 623 - 636
  • [8] Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease
    Whitwell, Jennifer L.
    Weigand, Stephen D.
    Shiung, Maria M.
    Boeve, Bradley F.
    Ferman, Tanis J.
    Smith, Glenn E.
    Knopman, David S.
    Petersen, Ronald C.
    Benarroch, Eduardo E.
    Josephs, Keith A.
    Jack, Clifford R., Jr.
    BRAIN, 2007, 130 : 708 - 719
  • [9] Diagnostic value of CSF chromogranin A to discriminate between Alzheimer's disease and dementia with Lewy bodies
    Bousiges, Olivier
    Lavaux, Thomas
    Demuynck, Catherine
    Schaeffer-Agalede, Caroline
    Philippi, Nathalie
    Muller, Candice
    Cretin, Benjamin
    Blanc, Frederic
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2024, 50 (01)
  • [10] Atrophy is associated with posterior cingulate white matter disruption in dementia with Lewy bodies and Alzheimer's disease
    Firbank, Michael J.
    Blamire, Andrew M.
    Krishnan, Mani S.
    Teodorczuk, Andrew
    English, Philip
    Gholkar, Anil
    Harrison, Roger
    O'Brien, John T.
    NEUROIMAGE, 2007, 36 (01) : 1 - 7